Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia
· Delayed Price · Currency is SAR 122.00
+1.00 (0.83%)
Apr 29, 2026, 3:17 PM AST
Dallah Healthcare Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 4,067 | 3,206 | 2,943 | 2,488 | 2,105 | Upgrade
|
| Revenue Growth (YoY) | 26.86% | 8.93% | 18.28% | 18.18% | 59.69% | Upgrade
|
| Cost of Revenue | 2,678 | 2,073 | 1,921 | 1,631 | 1,361 | Upgrade
|
| Gross Profit | 1,389 | 1,133 | 1,021 | 857.34 | 744.2 | Upgrade
|
| Selling, General & Admin | 771.47 | 560.22 | 519.68 | 437.06 | 399.18 | Upgrade
|
| Other Operating Expenses | -26.34 | -25.11 | -33.87 | -4.06 | -33.46 | Upgrade
|
| Operating Expenses | 794.75 | 565.51 | 515.07 | 439.05 | 382.82 | Upgrade
|
| Operating Income | 594.4 | 567.16 | 506.4 | 418.29 | 361.38 | Upgrade
|
| Interest Expense | -147.6 | -106.69 | -104.14 | -70.49 | -36.5 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.01 | 3.08 | 3.18 | Upgrade
|
| Earnings From Equity Investments | 51.7 | 42.97 | -1.86 | -22.82 | -31.08 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -5.33 | Upgrade
|
| EBT Excluding Unusual Items | 498.52 | 503.45 | 400.42 | 328.06 | 291.65 | Upgrade
|
| Gain (Loss) on Sale of Investments | 51.43 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.43 | -0.05 | -0.1 | 1.07 | 0.19 | Upgrade
|
| Other Unusual Items | 0 | - | - | - | - | Upgrade
|
| Pretax Income | 549.53 | 503.4 | 400.32 | 329.13 | 291.84 | Upgrade
|
| Income Tax Expense | 8.99 | 18.22 | 14.89 | 33.69 | 16.93 | Upgrade
|
| Earnings From Continuing Operations | 540.54 | 485.18 | 385.42 | 295.44 | 274.91 | Upgrade
|
| Minority Interest in Earnings | -2.27 | -13.97 | -25.3 | -20.98 | -16.31 | Upgrade
|
| Net Income | 538.27 | 471.2 | 360.12 | 274.46 | 258.6 | Upgrade
|
| Net Income to Common | 538.27 | 471.2 | 360.12 | 274.46 | 258.6 | Upgrade
|
| Net Income Growth | 14.23% | 30.84% | 31.21% | 6.13% | 95.92% | Upgrade
|
| Shares Outstanding (Basic) | 101 | 98 | 97 | 90 | 90 | Upgrade
|
| Shares Outstanding (Diluted) | 101 | 98 | 97 | 90 | 90 | Upgrade
|
| Shares Change (YoY) | 3.74% | 0.20% | 8.16% | - | 4.56% | Upgrade
|
| EPS (Basic) | 5.32 | 4.83 | 3.70 | 3.05 | 2.87 | Upgrade
|
| EPS (Diluted) | 5.32 | 4.83 | 3.70 | 3.05 | 2.87 | Upgrade
|
| EPS Growth | 10.12% | 30.59% | 21.31% | 6.13% | 87.38% | Upgrade
|
| Free Cash Flow | 90.1 | 314.65 | 331.28 | 269.44 | 245.93 | Upgrade
|
| Free Cash Flow Per Share | 0.89 | 3.23 | 3.40 | 2.99 | 2.73 | Upgrade
|
| Dividend Per Share | 2.000 | 2.000 | 1.500 | 2.500 | 1.500 | Upgrade
|
| Dividend Growth | - | 33.33% | -40.00% | 66.67% | 100.00% | Upgrade
|
| Gross Margin | 34.16% | 35.33% | 34.71% | 34.46% | 35.35% | Upgrade
|
| Operating Margin | 14.62% | 17.69% | 17.21% | 16.81% | 17.17% | Upgrade
|
| Profit Margin | 13.23% | 14.70% | 12.24% | 11.03% | 12.28% | Upgrade
|
| Free Cash Flow Margin | 2.22% | 9.81% | 11.26% | 10.83% | 11.68% | Upgrade
|
| EBITDA | 770.57 | 682.13 | 610.37 | 514.18 | 458.56 | Upgrade
|
| EBITDA Margin | 18.95% | 21.28% | 20.74% | 20.67% | 21.78% | Upgrade
|
| D&A For EBITDA | 176.17 | 114.97 | 103.97 | 95.89 | 97.18 | Upgrade
|
| EBIT | 594.4 | 567.16 | 506.4 | 418.29 | 361.38 | Upgrade
|
| EBIT Margin | 14.62% | 17.69% | 17.21% | 16.81% | 17.17% | Upgrade
|
| Effective Tax Rate | 1.64% | 3.62% | 3.72% | 10.24% | 5.80% | Upgrade
|
| Advertising Expenses | 84.96 | 48.65 | 39.82 | 25.92 | 25.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.